C. Cristalli

发表

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response

M. Esteller, A. Merkel, A. Mai, 2022, Frontiers in Endocrinology.

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

M. Ferracin, P. Lollini, P. Picci, 2019, Scientific Reports.

A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response

K. Scotlandi, M. Pasello, M. Manara, 2022, Polymers.

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

P. Lollini, K. Scotlandi, M. Serra, 2022, Cellular oncology.

Therapeutic vulnerability to PARP1,2 inhibition in RB1-mutant osteosarcoma

C. Steele, S. Strauss, S. Mittnacht, 2020, Nature Communications.

A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy

A. Mai, P. Lollini, P. Picci, 2018, Molecular Cancer Therapeutics.

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity

P. Lollini, K. Scotlandi, D. Donati, 2019, Journal of Experimental & Clinical Cancer Research.

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

P. Lollini, K. Scotlandi, M. Serra, 2022, Cellular Oncology.

Targeting DNA Methylation Machinery in Pediatric Solid Tumors

C. Cristalli, Katia Scotlandi, 2024, Cells.

CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles

Y. Pignochino, Veronica De Giorgis, M. Sciandra, 2024, International Journal of Molecular Sciences.